A detailed history of Park Avenue Securities LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Park Avenue Securities LLC holds 59,791 shares of ABT stock, worth $6.93 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
59,791
Previous 68,145 12.26%
Holding current value
$6.93 Million
Previous $7.08 Million 3.73%
% of portfolio
0.08%
Previous 0.09%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$100.07 - $118.13 $835,984 - $986,858
-8,354 Reduced 12.26%
59,791 $6.82 Million
Q2 2024

Jul 09, 2024

BUY
$100.73 - $112.44 $590,076 - $658,673
5,858 Added 9.4%
68,145 $7.08 Million
Q1 2024

Apr 10, 2024

BUY
$109.52 - $120.96 $311,036 - $343,526
2,840 Added 4.78%
62,287 $7.08 Million
Q4 2023

Jan 10, 2024

BUY
$90.19 - $110.4 $11,003 - $13,468
122 Added 0.21%
59,447 $6.54 Million
Q3 2023

Oct 26, 2023

SELL
$95.53 - $114.62 $159,152 - $190,956
-1,666 Reduced 2.73%
59,325 $5.75 Million
Q2 2023

Jul 14, 2023

BUY
$100.78 - $112.29 $260,012 - $289,708
2,580 Added 4.42%
60,991 $6.65 Million
Q1 2023

Apr 18, 2023

BUY
$96.86 - $114.01 $431,123 - $507,458
4,451 Added 8.25%
58,411 $5.92 Million
Q4 2022

Jan 24, 2023

SELL
$95.06 - $111.52 $25,951 - $30,444
-273 Reduced 0.5%
53,960 $0
Q3 2022

Nov 01, 2022

SELL
$96.76 - $112.03 $290 - $336
-3 Reduced 0.01%
54,233 $5.25 Million
Q2 2022

Jul 27, 2022

BUY
$102.07 - $123.37 $370,718 - $448,079
3,632 Added 7.18%
54,236 $5.89 Million
Q1 2022

Apr 29, 2022

BUY
$114.02 - $139.04 $721,062 - $879,288
6,324 Added 14.28%
50,604 $5.99 Million
Q4 2021

Apr 08, 2022

BUY
$115.53 - $141.46 $803,973 - $984,420
6,959 Added 18.65%
44,280 $6.23 Million
Q3 2021

Oct 21, 2021

BUY
$116.66 - $129.06 $110,010 - $121,703
943 Added 2.59%
37,321 $4.41 Million
Q2 2021

Aug 05, 2021

BUY
$105.79 - $124.53 $129,275 - $152,175
1,222 Added 3.48%
36,378 $4.22 Million
Q1 2021

Apr 28, 2021

BUY
$108.84 - $128.23 $489,453 - $576,650
4,497 Added 14.67%
35,156 $4.21 Million
Q4 2020

Jan 20, 2021

BUY
$105.0 - $114.42 $296,415 - $323,007
2,823 Added 10.14%
30,659 $3.36 Million
Q3 2020

Nov 03, 2020

BUY
$91.64 - $111.29 $309,010 - $375,269
3,372 Added 13.78%
27,836 $3.03 Million
Q2 2020

Jul 30, 2020

BUY
$76.57 - $98.0 $36,141 - $46,256
472 Added 1.97%
24,464 $2.24 Million
Q1 2020

Apr 28, 2020

SELL
$62.82 - $91.86 $62,003 - $90,665
-987 Reduced 3.95%
23,992 $1.89 Million
Q4 2019

Feb 04, 2020

BUY
$78.51 - $87.4 $181,829 - $202,418
2,316 Added 10.22%
24,979 $2.17 Million
Q3 2019

Oct 18, 2019

BUY
$81.84 - $88.74 $474,099 - $514,070
5,793 Added 34.34%
22,663 $1.9 Million
Q2 2019

Jul 26, 2019

BUY
$72.88 - $85.0 $203,408 - $237,235
2,791 Added 19.82%
16,870 $1.42 Million
Q1 2019

May 02, 2019

BUY
$66.22 - $80.06 $932,311 - $1.13 Million
14,079 New
14,079 $1.12 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Park Avenue Securities LLC Portfolio

Follow Park Avenue Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Avenue Securities LLC with notifications on news.